# Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies

> **NCT04566614** · — · COMPLETED · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 128 (actual)

## Conditions studied

- Neoplasm, Colorectal
- Neoplasm of Lung
- Neoplasm, Bladder
- Neoplasms Pancreatic
- Biliary Tract Neoplasms
- Gastro Intestinal Stromal Tumour

## Interventions

- **OTHER:** ctDNA blood sampling

## Key facts

- **NCT ID:** NCT04566614
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-18
- **Primary completion:** 2023-07-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2025-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04566614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04566614, "Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04566614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*